Loading...

Remedent, Inc.

REMI•PNK
Healthcare
Medical - Instruments & Supplies
$0.001
$0.00(0.00%)
U.S. Market opens in 2h 36m

Remedent, Inc. (REMI) Stock Overview

Explore Remedent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14K
P/E Ratio-0.05
EPS (TTM)$-0.01
ROE-0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.05
3 Months$0.00
1 Year Target$0.00

REMI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Remedent, Inc. (REMI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 14K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.00%
1-Month Change
0.00%
3-Month Change
16.67%
6-Month Change
250.000%
Year-to-Date (YTD) Change
16.67%
1-Year Change
-97.59%
3-Year Change
-99.59%
5-Year Change
-99.63%
All-Time (Max) Change
-99.97%

Contact Information

https://www.remedent.com
32 9 241 58 80
Zuiderlaan 1-3, Gent, NaN, 9000

Company Facts

3 Employees
IPO DateMar 1, 2006
CountryBE
Actively Trading

Frequently Asked Questions